Staining
OK-101 improves conjunctival staining, ocular pain in phase 2 trial of dry eye disease
Okyo Pharma released new data from its phase 2 trial of OK-101, a lipid conjugated chemerin peptide agonist, which showed a 68% improvement in both conjunctival staining and ocular pain among patients with dry eye disease.
Water-free cyclosporine outperforms vehicle in reducing fluorescein staining in dry eye
A water-free cyclosporine 0.1% solution demonstrated superiority over vehicle in corneal fluorescein staining among adults with moderate to severe dry eye disease, according to a study conducted in China and published in JAMA Ophthalmology.
VIDEO: Preservative-free eye drops reduce corneal staining in dry eye disease
NEW ORLEANS — Research presented at Academy ’23 demonstrated that perfluorohexyloctane, which is indicated for dry eye disease, reduces corneal staining up to four times more than saline.
Early grading of corneal fluorescein staining may affect diagnosis, treatment of DED
The evaluation of dry eye disease severity and treatment success could significantly be affected by early grading of corneal fluorescein staining, according to a study published in The Ocular Surface.